Key statistics dashboard for Cosmos Health Inc. (COSM). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes.
Stock Data
| Price | $0.27 |
| Market Cap | $15M |
| Enterprise Value | $29.1M |
| Beta | 4.46 |
| Exchange | NASDAQ |
| Country | GR |
Valuation Multiples
| P/E Ratio | -0.42 |
| Price / Book | 0.79 |
| P/S | 0.20 |
| EV/EBITDA | -1.49 |
| EV/Sales | 0.39 |
| EV/FCF | -2.52 |
| P/FCF | -1.29 |
| Earnings Yield | -148.66% |
| FCF Yield | -77.47% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 10.27% |
| EBIT Margin | -28.34% |
| EBITDA Margin | -26.45% |
| Operating Margin | -24.65% |
| Net Margin | -33.08% |
| Return on Equity | -118.89% |
| Return on Assets | -39.68% |
| Return on Invested Capital | -46.45% |
| Return on Capital Employed | -68.27% |
Financial Health
| Current Ratio | 1.05 |
| Quick Ratio | 0.92 |
| Cash Ratio | 0.05 |
| Debt / Equity | 0.77 |
| Debt / Assets | 25.99% |
| Net Debt / EBITDA | -0.73 |
| Interest Coverage | -5.19 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -2.49 |
Per-Share Data
| Revenue per share | 1.23 |
| Book Value per share | 0.35 |
| Cash per share | 0.03 |
| FCF per share | -0.19 |
| Tangible Book Value per share | 0.20 |
| Dividend per share | 0.00 |
Related companies: CASI · CLSD · FEMY · IINN · LSTA · MTVA · NCNA
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of COSM: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks